DK2155179T3 - Axomadol til smertebehandling arthrose - Google Patents

Axomadol til smertebehandling arthrose

Info

Publication number
DK2155179T3
DK2155179T3 DK08758440.5T DK08758440T DK2155179T3 DK 2155179 T3 DK2155179 T3 DK 2155179T3 DK 08758440 T DK08758440 T DK 08758440T DK 2155179 T3 DK2155179 T3 DK 2155179T3
Authority
DK
Denmark
Prior art keywords
axomadol
arthrosis
pain management
pain
management
Prior art date
Application number
DK08758440.5T
Other languages
English (en)
Inventor
Klaus Schiene
Petra Bloms-Funke
John Bothmer
Claudia Lefeber
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK2155179T3 publication Critical patent/DK2155179T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK08758440.5T 2007-05-11 2008-05-09 Axomadol til smertebehandling arthrose DK2155179T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007022790A DE102007022790A1 (de) 2007-05-11 2007-05-11 Axomadol zur Schmerzbehandlung bei Arthrose
PCT/EP2008/003755 WO2008138558A1 (de) 2007-05-11 2008-05-09 Axomadol zur schmerzbehandlung bei arthrose

Publications (1)

Publication Number Publication Date
DK2155179T3 true DK2155179T3 (da) 2011-03-07

Family

ID=39672675

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08758440.5T DK2155179T3 (da) 2007-05-11 2008-05-09 Axomadol til smertebehandling arthrose

Country Status (21)

Country Link
US (2) US20080306161A1 (da)
EP (1) EP2155179B1 (da)
JP (1) JP2010526786A (da)
KR (1) KR20100017781A (da)
CN (1) CN101742993A (da)
AT (1) ATE489947T1 (da)
AU (1) AU2008250621A1 (da)
CA (1) CA2685379A1 (da)
CY (1) CY1111328T1 (da)
DE (2) DE102007022790A1 (da)
DK (1) DK2155179T3 (da)
ES (1) ES2357355T3 (da)
HR (1) HRP20110127T1 (da)
IL (1) IL202001A0 (da)
MX (1) MX2009012096A (da)
PL (1) PL2155179T3 (da)
PT (1) PT2155179E (da)
RU (1) RU2009145804A (da)
SI (1) SI2155179T1 (da)
WO (1) WO2008138558A1 (da)
ZA (1) ZA200907646B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110060053A1 (en) 2002-09-09 2011-03-10 Gruenenthal Gmbh Crystalline Modifications of 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol
WO2011008298A2 (en) * 2009-07-16 2011-01-20 Nectid, Inc. Novel axomadol dosage forms
WO2011023392A1 (en) 2009-08-28 2011-03-03 Grünenthal GmbH Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol or 6-dimethylaminomethyl-1-(3-hydroxy-phenyl)-cyclohexane-1,3-diol and an antiepileptic
US20120022294A1 (en) * 2010-06-30 2012-01-26 Gruenenthal Gmbh Axomadol or a Metabolite Thereof for Use in the Treatment of Irritable Bowel Syndrome

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE10004926A1 (de) * 2000-02-04 2001-08-09 Gruenenthal Gmbh Verfahren zur enzymatischen Racematspaltung von Aminomethyl-Aryl-Cyclohexanol-Derivaten
DE10059413A1 (de) * 2000-11-30 2002-06-20 Gruenenthal Gmbh Verwendung von substituierten 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz
DE10109763A1 (de) 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
US20050176790A1 (en) * 2001-02-28 2005-08-11 Johannes Bartholomaus Pharmaceutical salts
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
ATE465726T1 (de) * 2002-11-22 2010-05-15 Gruenenthal Gmbh Verwendung von (1r, 2r)-3-(3-dimenthylamino-1- ethyl-2-methyl-propyl)-phenol zur behandlung von entzündungsschmerz
DE10333835A1 (de) 2003-07-24 2005-03-10 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol enthaltendes Arzneimittel mit verzögerter Wirkstofffreisetzung
JP5259183B2 (ja) * 2004-07-01 2013-08-07 グリューネンタール・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 乱用に対して保護された経口剤形
DE102005009217A1 (de) * 2005-02-25 2006-08-31 Grünenthal GmbH Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen
KR20070112812A (ko) * 2005-02-25 2007-11-27 그뤼넨탈 게엠베하 (1rs,3rs,6rs)-6-디메틸아미노메틸-1-(3-메톡시-페닐)사이클로헥산-1,3-디올 하이드로클로라이드의 결정질 형태

Also Published As

Publication number Publication date
ATE489947T1 (de) 2010-12-15
HK1141436A1 (en) 2010-11-12
IL202001A0 (en) 2010-06-16
HRP20110127T1 (hr) 2011-03-31
ZA200907646B (en) 2010-07-28
EP2155179A1 (de) 2010-02-24
US20100331424A1 (en) 2010-12-30
AU2008250621A1 (en) 2008-11-20
PT2155179E (pt) 2011-03-07
KR20100017781A (ko) 2010-02-16
EP2155179B1 (de) 2010-12-01
PL2155179T3 (pl) 2011-05-31
SI2155179T1 (sl) 2011-03-31
DE102007022790A1 (de) 2008-11-20
JP2010526786A (ja) 2010-08-05
CA2685379A1 (en) 2008-11-20
MX2009012096A (es) 2009-11-23
DE502008001951D1 (de) 2011-01-13
ES2357355T3 (es) 2011-04-25
RU2009145804A (ru) 2011-06-20
CY1111328T1 (el) 2015-08-05
CN101742993A (zh) 2010-06-16
WO2008138558A1 (de) 2008-11-20
US20080306161A1 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
NL301145I2 (nl) Tirbanibulin
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
HUE038588T2 (hu) IL-22 mikrobiális rendellenességek kezelésében történõ alkalmazásra
EA201171367A1 (ru) Винилиндазолильные соединения
GB2464245A (en) Managing risk associated with various transactions
DK2114419T3 (da) Natriummetaarsenit til anvendelse i behandling af smerte og inflammation
PL2037902T3 (pl) Zastosowanie kanabidiolu w użyciu w leczeniu bólu neuropatycznego
EP2214495A4 (en) NATURALLY PHOTODYNAMIC ACTIVE SUBSTANCES AND ITS USE
CL2008002042A1 (es) Compuestos derivados de heterociclos nitrogenados enlazados; y su uso en el tratamiento de la diabetes y desordenes metabolicos.
EA201001372A1 (ru) Формы рифаксимина и их применение
IL249838A0 (en) Telomerase activating compounds for use in treating diseases related thereto
MY160041A (en) Compositions and methods for treating parasitic infections
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
MX379016B (es) Composiciones y metodos para tratar enfermedad de gaucher.
EA201170832A1 (ru) Пуриновые соединения
CL2012003385A1 (es) Tratamiento para la incontinencia.
HRP20160569T1 (hr) Boropeptidni inhibitori enteropeptidaze i njihove uporabe u liječenju pretilosti, pretjerane tjelesne težine i/ili bolesti povezane s abnormalnim metabolizmom masti
MX2011007930A (es) Conjugados de insulina cristalina.
BRPI0816712A2 (pt) terapia de intervalo para o tratamento de tinnitus
EP2373658A4 (en) STAT3 INHIBITORS AND THERAPEUTIC PROCEDURES WHERE THEREOF ARE USED
EP3381471C0 (en) PAIN TREATMENT
MX2009011346A (es) Tapentadol para tratamiento de dolor con artritis.
BRPI0814772A2 (pt) Indazóis substituídos por 5-piridinona
BRPI0822129A2 (pt) Inibidores de aldh-2c no tratamento de vício.